Vonoprazan Study of Investigating the Effect on Sleep Disturbance Associated With Reflux Esophagitis- Exploratory Evaluation (VISTAEXE)
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 01 Dec 2017
At a glance
- Drugs Vonoprazan (Primary)
- Indications Reflux oesophagitis
- Focus Therapeutic Use
- Acronyms VISTAEXE
- Sponsors Takeda
- 28 Nov 2017 Status changed from recruiting to active, no longer recruiting.
- 29 Aug 2017 Planned End Date changed from 31 Dec 2017 to 30 Dec 2017.
- 28 Aug 2017 Planned primary completion date changed from 31 Dec 2017 to 30 Dec 2017.